SCHEMBL8010663

SCHEMBL8010663

CCOC(=O)c1sc2cc(C)ccc2c1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.67
MCL1 Q07820 1/20 0.67
MAPT P10636 7/20 0.65
NPC1 O15118 6/20 0.65
RAB9A P51151 6/20 0.65
LMNA P02545 3/20 0.65
GAA P10253 2/20 0.65
SMN1; SMN2 Q16637 4/20 0.53
PPARG P37231 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HPGD P15428 2/20 0.49
RXFP1 Q9HBX9 2/20 0.49
TP53 P04637 1/20 0.49
PKM P14618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8010924 0.89 MCL1 (0.52) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL8020988 0.87 CYP4F2 (0.54) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL6824033 0.86 MAPT (0.49) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL31483496 0.86 MAPT (0.49) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL5023563 0.85 MCL1 (0.70) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL8024989 0.84 MAPT (0.48) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL30099150 0.83 LMNA (0.48) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL28836579 0.83 LMNA (0.48) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL5023231 0.80 MCL1 (0.77) BCL2L1MCL1MAPTNPC1RAB9A
SCHEMBL417349 0.80 MCL1 (1.00) BCL2L1MCL1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6040309-A ACTIVE MATERIAL TREATING OF RESTENOSIS, RENAL FAILURE, PULMONARY HYPERTENSION, BENIGN PROSTATIC HYPERTROPHY, MALE ERECTILE DYSFUNCTION, CONGESTIVE HEART FAILURE, STROKE, ANGINA, ATHEROSCLEROSIS, CEREBRAL AND CARDIAC ISCHAEMIA PFIZER, INC. (US) 2000-03-21 US disclosed
EP-0921124-A1 Benzothiophene derivatives useful in therapy Pfizer Limited (GB) 1999-06-09 EP disclosed